$アコヤ バイオサイエンシズ(AKYA.US)$Preliminary earnings looking pretty positive. The company also forecasts that they will achieve operating cash flow break even by the EOY! Seems there is some pretty good news of several fronts
$アコヤ バイオサイエンシズ(AKYA.US)$Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow! And they also announced that they have deployed MaxFuse Algorithm! Developed by Dr Garry Nolan at Stamford University for Multiomic Integration of Spatial and Single-Cell Data on the Enable Medicine Platform
アコヤ バイオサイエンシズに関するコメント
$ビオラ セラピューティクス(BIOR.US)$
$アコヤ バイオサイエンシズ(AKYA.US)$
$タリムン(THAR.US)$
$Bit Brother(BETS.US)$
And they also announced that they have deployed MaxFuse Algorithm! Developed by Dr Garry Nolan at Stamford University for Multiomic Integration of Spatial and Single-Cell Data on the Enable Medicine Platform
• $ブリックスモア・プロパティグループ(BRX.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $25 (from $27)
• $シグナ グループ(CI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $296 (from $283)
• $エナパック ツール グループ A(EPAC.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $23 (from $22)
• $エクイティ・レジデンシャル(EQR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $79 (from $95)
• $エクストラ・スペース・ストレージ(EXR.US)$ : JPMorga...
まだコメントはありません